BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35805200)

  • 1. A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma.
    Hu H; Huang W; Zhang H; Li J; Zhang Q; Miao YR; Hu FF; Gan L; Su Z; Yang X; Guo AY
    Cells; 2022 Jul; 11(13):. PubMed ID: 35805200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-20b-5p promotes hepatocellular carcinoma cell proliferation, migration and invasion by down-regulating CPEB3.
    Li Z; Wu L; Tan W; Zhang K; Lin Q; Zhu J; Tu C; Lv X; Jiang C
    Ann Hepatol; 2021; 23():100345. PubMed ID: 33812045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-18a-5p Facilitates Progression of Hepatocellular Carcinoma by Targeting CPEB3.
    Cui M; Qu F; Wang L; Cheng D; Liu X
    Technol Cancer Res Treat; 2021; 20():15330338211043976. PubMed ID: 34738854
    [No Abstract]   [Full Text] [Related]  

  • 4. LINC01018 confers a novel tumor suppressor role in hepatocellular carcinoma through sponging microRNA-182-5p.
    Wang S; Xu M; Sun Z; Yu X; Deng Y; Chang H
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G116-G126. PubMed ID: 31021172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-3174 promotes proliferation and inhibits apoptosis by targeting FOXO1 in hepatocellular carcinoma.
    Wang Q; Yang X; Zhou X; Wu B; Zhu D; Jia W; Chu J; Wang J; Wu J; Kong L
    Biochem Biophys Res Commun; 2020 Jun; 526(4):889-897. PubMed ID: 32279994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-9-5p promotes cell proliferation and migration of hepatocellular carcinoma by targeting CPEB3.
    Shu Z; Gao F; Xia Q; Zhang M
    Biomark Med; 2021 Feb; 15(2):97-108. PubMed ID: 33496636
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification and Verification of a Novel MAGI2-AS3/miRNA-374-5p/FOXO1 Network Associated with HBV-Related HCC.
    Wang C; Su K; Lin H; Cen B; Zheng S; Xu X
    Cells; 2022 Nov; 11(21):. PubMed ID: 36359865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircRNA hsa_circ_0110102 inhibited macrophage activation and hepatocellular carcinoma progression via miR-580-5p/PPARα/CCL2 pathway.
    Wang X; Sheng W; Xu T; Xu J; Gao R; Zhang Z
    Aging (Albany NY); 2021 Apr; 13(8):11969-11987. PubMed ID: 33891564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-224 Executes a Tumor Accelerative Role during Hepatocellular Carcinoma Malignancy by Targeting Cytoplasmic Polyadenylation Element-Binding Protein 3.
    Miao K; Liu SD; Huang WX; Dong H
    Pharmacology; 2020; 105(7-8):477-487. PubMed ID: 32454494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mir-452-3p: A Potential Tumor Promoter That Targets the CPEB3/EGFR Axis in Human Hepatocellular Carcinoma.
    Tang H; Zhang J; Yu Z; Ye L; Li K; Ding F; Feng X; Meng W
    Technol Cancer Res Treat; 2017 Dec; 16(6):1136-1149. PubMed ID: 29332449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRNDE-h transcript/miR-136-5p axis regulates interleukin enhancer binding factor 2 expression to promote hepatocellular carcinoma cell proliferation.
    Shiu TY; Lin HH; Shih YL; Feng AC; Huang HH; Huang TY; Hsieh CB; Chang WK; Hsieh TY
    Life Sci; 2021 Nov; 284():119708. PubMed ID: 34153299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-1269 promotes proliferation in human hepatocellular carcinoma via downregulation of FOXO1.
    Yang XW; Shen GZ; Cao LQ; Jiang XF; Peng HP; Shen G; Chen D; Xue P
    BMC Cancer; 2014 Dec; 14():909. PubMed ID: 25472505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma.
    Duan X; Li W; Hu P; Jiang B; Yang J; Zhou L; Mao X; Tian B
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33078826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma.
    Lin X; Zuo S; Luo R; Li Y; Yu G; Zou Y; Zhou Y; Liu Z; Liu Y; Hu Y; Xie Y; Fang W; Liu Z
    Theranostics; 2019; 9(25):7583-7598. PubMed ID: 31695788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK3 homeobox 1 (NKX3.1) up-regulates forkhead box O1 expression in hepatocellular carcinoma and thereby suppresses tumor proliferation and invasion.
    Jiang J; Liu Z; Ge C; Chen C; Zhao F; Li H; Chen T; Yao M; Li J
    J Biol Chem; 2017 Nov; 292(47):19146-19159. PubMed ID: 28972178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

  • 18. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression.
    Compagnoni C; Capelli R; Zelli V; Corrente A; Vecchiotti D; Flati I; Di Vito Nolfi M; Angelucci A; Alesse E; Zazzeroni F; Tessitore A
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-769-5p contributes to the proliferation, migration and invasion of hepatocellular carcinoma cells by attenuating RYBP.
    Xian Y; Wang L; Yao B; Yang W; Mo H; Zhang L; Tu K
    Biomed Pharmacother; 2019 Oct; 118():109343. PubMed ID: 31545279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.